## Clinical Scenario Analysis This patient presents with classic **Pneumocystis jirovecii pneumonia (PCP)** in the setting of severe immunosuppression (CD4 <200 cells/μL). The constellation of dyspnea, fever, dry cough, bilateral interstitial infiltrates, and hypoxemia (PaO₂ 65 mmHg) is pathognomonic. ## Management Algorithm ```mermaid flowchart TD A[CD4 < 200 + respiratory symptoms]:::outcome --> B{Suspected PCP?}:::decision B -->|Yes| C[Initiate TMP-SMX prophylaxis immediately]:::action C --> D[Perform diagnostic confirmation]:::action D -->|Sputum induction or bronchoscopy| E[Obtain diagnosis] E --> F[Start ART without delay]:::action F --> G[Monitor for IRIS]:::outcome B -->|No| H[Alternative diagnosis] ``` ## Key Management Principles **Key Point:** In patients with CD4 <200 cells/μL and suspected PCP, **do NOT wait for diagnostic confirmation to start prophylaxis**. TMP-SMX is both therapeutic and prophylactic. **High-Yield:** The three pillars of PCP management in advanced HIV: 1. **Immediate TMP-SMX initiation** (15–20 mg/kg/day trimethoprim component) 2. **Diagnostic confirmation** via sputum induction (induced sputum with LDH staining) or bronchoscopy with bronchoalveolar lavage (BAL) if sputum negative 3. **Concurrent ART initiation** — do NOT delay antiretroviral therapy waiting for clinical improvement **Clinical Pearl:** Hypoxemia (PaO₂ <70 mmHg) is an indication for adjunctive **corticosteroids** (prednisone 40 mg BD tapering over 21 days) to reduce inflammation and mortality. **Warning:** ~~Deferring PCP prophylaxis until CD4 >200~~ is incorrect — prophylaxis must start immediately when CD4 <200 or PCP is suspected, regardless of ART status. ## Why Immediate ART? - ART initiation should **not be delayed** for diagnostic confirmation or symptom resolution. - Early ART (within 2 weeks of OI diagnosis) improves outcomes and reduces mortality. - The risk of **immune reconstitution inflammatory syndrome (IRIS)** exists but is outweighed by the benefit of immune recovery. [cite:Harrison 21e Ch 197]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.